PMDA drug package insert
デュロテップMTパッチ2.1mg
PMDA Prescription drug · ヤンセンファーマ株式会社 · package insert Dec 23, 2024
Key facts
| Brand names | デュロテップMTパッチ2.1mg, デュロテップMTパッチ4.2mg, デュロテップMTパッチ8.4mg, デュロテップMTパッチ12.6mg, デュロテップMTパッチ16.8mg |
|---|---|
| Nonproprietary names | フェンタニル |
| Companies | 製造販売元（輸入）／ヤンセンファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 経皮吸収型 持続性疼痛治療剤 |
| Therapeutic category codes | 878219 |
| YJ codes | 8219700S5026, 8219700S6022, 8219700S7029, 8219700S8025, 8219700S9021 |
| Approval numbers | 22000AMX01422000, 22000AMX01423000, 22000AMX01424000, 22000AMX01425000, 22000AMX01426000 |
| Package insert edition | 第3版 |
| Package insert date | Dec 23, 2024 |
| PMDA document key | 800155_8219700S5026_1 |
| PMDA company code | 800155 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: